Tricida, Inc. (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- March 04, 2015
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $30,000,000
Company Info
- Founders
- Gerrit Klaerner
- Company Description
- Tricida, Inc., is a pre-clinical-stage biopharmaceutical company focused on the discovery and development of first-in-class therapeutics. Tricida's lead program is TRC101, a chronic treatment for complications of renal disease.
- Market
- Renal disease therapeutics
- Location
- South San Francisco, California, USA
- Coinvestors
- Limulus Venture Partners, OrbiMed Advisors, Sibling Capital